Search Results 1131-1140 of 18764 for Relapse
MF patients must have received prior JAK2 inhibitor therapy, and been found to be intolerant, or refractory/relapsed from prior JAK2 inhibitor therapy, based on ...
Both newly diagnosed and relapsed refractory patients with AML will be assigned to different cohorts based on specific study criteria and physician discretion.
1b Patients only). - Histologically confirmed relapsed/recurrent CLL in whom venetoclax is appropriate standard salvage treatment; no prior venetoclax is ...
Immunotherapy also may be combined with other medicines to treat advanced cancer or cancer that has come back after treatment, known as relapsed mantle cell ...
Subject who has documented active relapsed or refractory disease requiring therapeutic intervention. Subject with lymphoma who has measurable disease ...
... relapse immediately prior to the transplant;; If disease relapse prior to transplant and the patient did have treatment for the relapsed disease prior to ...
For Part A: - Participants With AML: treatment naive or relapsed for whom experimental therapy is appropriate (as assessed by their treating physician) For Part ...
Patients who undergo lower respiratory testing solely to evaluate for relapsed malignancy will be excluded. Participating Mayo Clinic locations. Study ...
metastatic disease that is relapsed or refractory to at least one line of post-adjuvant therapy (including a CPI-either alone or in combination if approved
... relapsed following at least 2 prior therapies) or for which no standard therapy is known to exist. For the Neuroendocrine (NET) and adrenocortical carcinoma ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.